Compare Summit Therapeutics Inc (SMMT) vs Wayfair Inc (W) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Summit Therapeutics Inc vs Wayfair Inc — how do they compare? Summit Therapeutics Inc trades at $14.57 (market cap $10.48B), while Wayfair Inc trades at $84.8 (market cap $11.58B). The key difference: Summit Therapeutics Inc and Wayfair Inc are close in size by market cap, and Wayfair Inc is trading nearer its 52-week high, Summit Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| SMMT | W | |
|---|---|---|
Market Cap | $10.48B | $11.58B |
Sector | Health | Consumer Cyclical |
52-Week High | $29.32 | $119.05 |
52-Week Low | $13.05 | $56.42 |
Enterprise Value | $9.90B | $14.16B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →About Wayfair Inc
Wayfair is a global leader in home goods, operating a massive digital marketplace that connects millions of consumers with thousands of suppliers. It utilizes an asset-light, inventory-light model combined with a proprietary logistics network (CastleGate) and an accelerating brick-and-mortar presence to deliver an end-to-end shopping experience for everything from decor to full home renovations.
Read more on W →
